Cataracts, a clouding of the eye lens, are a common eye
disorder among the population. According to the Center for Disease Control,
approximately 20.5 million, or 17.2% of Americans age 40 years or older, have a
cataract in one or both eyes. The numbers continue to grow and data suggests
that by the year 2020, 30.1 million Americans will have cataracts in at least
one eye.
A routine surgery can be performed in which a small incision
is made in the eye and the clouded lens is removed and replaced by a new
permanent intraocular implant. During surgery the implant is stored in a
solution until ready for implantation, however there have been many reported
cases in which during the fluid-air exchange from solution to insertion, the
lens develops a foggy film reducing the effectiveness of the surgery.
Researchers at Arizona State University have developed a new
molecular film for implant surfaces that eliminates the foggy film that can
occur during the fluid air exchange. The new technology consists of a bilayer
solution that effectively inhibits the foggy film, maintains the lens’s clarity
for longer than current solutions, and can be created entirely from FDA approved
materials.
Potential Applications
- Goggles
- Eye Glasses
- Airplane Wings
- Paint
- Hair Care Products
- Mirrors
- Stainless Steel
- Clothing
- Microfluidics
Benefits and Advantages
- Elimination of the foggy film during the fluid air
exchange
- More effective surgeries for both surgeons and patients
- Viable for a longer period of time during surgery
compared to other products
- Longer shelf life than other current products
Download Orginal PDF
